Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

How BARDA Locked Up COVID-19 Vaccine Manufacturing Capacity For Operation Warp Speed

Jul 30 2020

• By Bowman Cox

Flexible Biomanufacturing Facility at Texas A&M — ciadm facilities dedicated to 'warp speed' vaccine manufacturing • Source: TAMUS

Related Content

Regeneron COVID-19 Therapeutic, Novavax Vaccine Get BARDA Funding To Boost Manufacturing

Jul 08 2020

BARDA Scales Up COVID-19 Vaccine Manufacturing Capacity With $628m For Emergent BioSolutions

Jun 01 2020

Kalon Stake Gives Fujifilm Ebola Vaccine Capacity

Oct 27 2014

Merck & Co offloads contract biomanufacturing ops to Fujifilm

Mar 01 2011

Related Companies

Emergent BioSolutions, Inc.

Texas A&M University

Novavax, Inc.

FUJIFILM Diosynth Biotechnologies

Merck & Co., Inc.

Additional Topics

United States Coronavirus COVID-19 Manufacturing Vaccines BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window